Industry Developments

BMI View: The increase in medicine freight service between Brazil, Argentina and the UAE will strengthen the ties between these countries and benefit pharmaceutical companies, which... 2012-01-19

BMI Core View: Offshoring manufacturing to low-cost bases will accelerate. Multinational drugmakers are looking to cut costs during the patent cliff and production is being shifted... 2012-01-18

BMI View: Multinational drugmakers are increasingly seeking expansion in Latin America to reduce their dependence on the slow-growing markets in Europe and the US. The region's two... 2012-01-17

BMI View: Multinational pharmaceutical companies will find opportunities for sales growth in niche markets in Latin American countries, particularly ones that have relatively high burden... 2012-01-16

BMI View: Corporate social responsibility (CSR) is an underappreciated business activity in the pharmaceutical industry. Like all commercial entities, drugmakers are fully entitled... 2012-01-13

BMI View: Mexico's pharmaceutical market has many fundamental characteristics that are attracting drugmakers, including relatively high urbanisation, a significant chronic disease burden... 2012-01-12

BMI View: Cuba's firm control of many infectious diseases shows the country's capabilities in healthcare in general and pharmaceutical development in particular. However, under the... 2012-01-11

BMI View: Emerging markets will drive medical device industry growth. The importance of emerging markets to large multinational medical equipment producers cannot be overstated and... 2012-01-10

BMI View: The prevalence of diabetes in many countries is likely to be underestimated because of inaccurate census and epidemiological data. Governments should aim to generate better... 2012-01-09

BMI View: When pharmaceutical companies enter a new market they should make sure their products fit the market needs and tailor their strategic endeavours to avoid unnecessary costs,... 2012-01-06